Endoscopic Algorithm for Management of Gastrointestinal Bleeding in Patients With Continuous Flow LVADs: A Prospective Validation Study

Continuous flow-left ventricular assist device (CF-LVAD) technology has reduced mortality and improved the quality of life in patients with advanced heart failure (HF) refractory to medical therapy.1,2 Despite a significant reduction in adverse events with the latest generation of CF-LVADs, gastrointestinal bleeding (GIB) continues to be the most common complication and a significant source of morbidity. GIB accounts for high rates of hospital readmissions, with a reported incidence ranging from 17.6% to 61%.

Source: Journal of Cardiac Failure - November 30, 2019 Category: Cardiology Authors: Jordan E. Axelrad, Adam S. Faye, Alberto Pinsino, Anusorn Thanataveerat, Barbara Cagliostro, Marie Finelle T. Pineda, Katherine Ross, Rosie T. Te-Frey, Lisa Effner, Arthur R. Garan, Veli K. Topkara, Hiroo Takayama, Koji Takeda, Yoshifumi Naka, Ivonne Rami Source Type: research